Exhaled NO but not eosinophilic inflammation is reduced by inhaled corticosteroid treatment in COPD Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013
Relation of exhaled breath temperature and systemic markers of inflammation and remodelling in stable bronchial asthma Source: International Congress 2016 – Airway biomarkers Year: 2016
Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008
Prediction of CF exacerbations in children by exhaled inflammation markers Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015
Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013
Exhaled breath condensate for evaluation of inflammation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006
Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008
Influence of inflammatory phenotype in severe refractory asthma on metabolomic profile of oxidative stress in exhaled breath condensate (EBC) Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013
Clinically relevant early functional and diagnostic markers of lung disease in children Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=120 Year: 2006
Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008
Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF Source: Eur Respir J 2006; 28: Suppl. 50, 353s Year: 2006
Inflammatory markers in exhaled breath condensate of two COPD phenotypes Source: Eur Respir J 2005; 26: Suppl. 49, 260s Year: 2005
Unbiased clustering of severe asthma patients based on exhaled breath profiles Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015
Exhaled markers in the monitoring of airways inflammation in mild persistent asthma Source: Eur Respir J 2004; 24: Suppl. 48, 679s Year: 2004
Inflammatory markers in exhaled breath condensate in bronchiectasis Source: Eur Respir J 2004; 24: Suppl. 48, 707s Year: 2004
Exhaled breath condensate hydrogen peroxide in obstructive airways disease Source: International Congress 2014 – Airway biomarkers Year: 2014
Noninvasive assessment of airway inflammation in asthma Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=164 Year: 2003
Changes in PH of exhaled breath condensate after specific inhalation challenge test, in patients with hypersensitivity pneumonitis Source: International Congress 2014 – ILDs 3 Year: 2014
Exhaled breath temperature increases at COPD exacerbation and correlates with sputum neutrophilia Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011
Markers of airway diseases in exhaled breath condensate and their clinical value Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013